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Abstract
Tubercle bacillus [TB] is one of the most important chronic infectious diseases that cause millions of deaths
annually. While conventional smear microscopy and culture methods are widely used for diagnosis of TB, the
former is insensitive, and the latter takes up to 6 to 8 weeks to provide a result, limiting the value of these
methods in aiding diagnosis and intermediate decisions on treatment. Therefore, a rapid detection method is
essential for the diagnosis, prognosis assessment, and recurrence monitoring. A new surface plasmon resonance
[SPR] biosensor based on an array format, which allowed immobilizing nine TB antigens onto the sensor chip, was
constructed. Simultaneous determination of multiple TB antibodies in serum had been accomplished with this
array-based SPR system. The results were compared with enzyme-linked immunosorbent assay, a conventional
immunological method. Array-based SPR showed more advantages in providing label-free and real-time detection.
Additionally, the high sensitivity and specificity for the detection of TB infection showed its potential for future
development of biosensor arrays for TB diagnosis.
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Background
Mycobacterium tuberculosis [MTB] is the causative agent
of tubercle bacillus [TB], accounting for approximately
two million deaths annually, mainly in developing coun-
tries [1], and remains one of the leading causes of
respiratory infections and has posed critical threats to
public health [2]. Currently, the global number of TB
cases is rising at a rate of 2% per year [3]. Hence, the key
to the control of this infectious disease is to provide the
short course therapy and the post-exposure vaccine.
Moreover, the rapid detection method with high sensitiv-
ity and specificity is essential to aid the diagnosis, assess
the prognosis, and monitor the disease recurrence [4].
Until now, many analytical methods have been applied
to the routine detection of MTB, which include the stain-
ing of acid-fast bacilli [AFB], cultivation and numerous
serological and biochemical tests such as polymerase chain
reaction [PCR] and enzyme immunoassay [EIA] for identi-
fication [5-8]. AFB has been evaluated on sputum samples,
giving simple operation but relatively poor sensitivity [9].
Although cultivation usually provides reliable and accurate
results, it requires several weeks to obtain a result due to
the slow-growing nature of these mycobacteria [10]. PCR-
based methods are useful techniques for amplification of
small amounts of genetic material but require complicated
sample prepurification before analysis. EIA employing
multiple antibody probes for bacteria detection leads to
both the complexity and the cost of the method. Hence,
there are still needs to develop better technologies that
can reduce detection complexity and perform faster diag-
nosis while maintaining high sensitivity and specificity.
The uses of nanoparticles and electrochemical and optical
methods for nucleic acid detection have been explored
extensively [1,11,12]. Other strategies based on antibody-
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provided the original work is properly cited.antigen recognition with fluorescence and microgravi-
metric techniques for analyses of MTB were reported
recently [13]. In contrast to the detection of antigen, the
bioassay based on antibody detection is an alternative
approach for latent TB. Detection of expressed TB poly-
clonal antibodies is more useful than detection of the
monoclonal antibodies since such an antibody may not be
expressed in TB-infected individuals, resulting in the poor
performance of the TB detection [14]. A multiantigen
print immunoassay has been recently employed for profil-
ing multiple antibodies to tuberculosis [15]. Nonetheless,
this immunoassay requires longer incubation time to carry
out the antibody-antigen interaction compared with other
biosensors.
Surface plasmon resonance [SPR] has attracted much
attention because of several important properties. The
main advantage of an SPR-based assay is that it is an
extremely sensitive optical sensor, capable of detecting
subnanogram levels in real time without any specific label
[16]. Moreover, a SPR biosensor can detect trace amounts
of specific analytes from complex fluids without sample
preparation [17]. Due to these advantages, SPR has
emerged as a powerful optical tool that can greatly provide
valuable information on biomedical and chemical analyses
[16-20]. In addition, several groups have developed multi-
spot SPR for studying the biomolecular interaction with
an array format [21-23]. This technique provides a possi-
ble means of quick and simultaneous detection for obser-
ving many interaction events and is thus considered as a
promising technique for proteome profiling methods.
However, to our knowledge, no attempt has been reported
to use the SPR-based biosensor for clinical antibody detec-
tion of TB diseases in a parallel manner.
In the present study, we developed a new SPR-based
biosensor for clinical antibody detection of TB diseases
in a parallel manner for the first time. The sensitivity,
specificity, and reproducibility of the array-based SPR
results were evaluated and finally compared to those of
enzyme-linked immunosorbent assay [ELISA], a conven-
tional immunological method.
Materials and methods
Chemicals and materials
N-hydroxysuccinimide [NHS], 8-mercaptooctanoic acid
(C8H16O2S) [8-MOA], phosphate-buffered saline [PBS],
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydro-
chloride [EDC], bovine serum albumin [BSA], and etha-
nolamine were purchased from Sigma (St. Louis, MO,
U S A )a n du s e da sr e c e i v e d .T h en i n ep u r i f i e da n t i g e n s
were listed in Table 1 and were provided by the National
Taiwan University Hospital (Taipei, Taiwan). A total of
57 serum samples from different individuals (n = 57) was
evaluated. The serum samples of TB patients (n =2 9 )
and of healthy individuals (n = 28) were obtained from
the National Taiwan University Hospital. All healthy
individuals were detected negative of TB infection by tra-
ditional MTB diagnostic methods and medical history.
Array chip preparation
Twenty-five-spot protein arrays were designed and fabri-
cated by thin film deposition and photolithography. The
sizes of arrays were 2 mm in diameter, and the center-to-
center spacing between all adjacent spots was set to 3 mm.
8-MOA in ethanol was dripped onto the array surface at
room temperature and allowed to form a self-assembled
monolayer for 30 min. The array surface was further trea-
ted with 400 mM EDC/100 mM NHS for 10 min to active
carboxyl groups of 8-MOA. The nine different antigens, at
a concentration of 50 μg/mL, were then applied to the
spots of the protein arrays for 1 h, and the arrays were
blocked with 1 M ethanolamine for 10 min. The BSA was
used as the negative control and did not show significant
binding reaction to patients’ serum antibodies. The mix-
ture of nine MTB antigens previously purified in the
laboratory was deposited in one spot and used as the posi-
tive control (Figure 1 and Table 1). The chips were rinsed
with PBS buffer and then stored at 4°C for further use.
SPR measurements
SPR measurements were conducted using the GWC SPRi-
mager system (GWC Technologies, Madison, WI, USA) as
described elsewhere [17]. Briefly, the images were observed
at the fixed angle which was slightly smaller than the SPR
angle and collected with a CCD camera at 790 nm. The
SPR signal data were collected with a V++ 4.0 program
(Digital Optics, Auckland, New Zealand). The measured
response values are expressed as ΔR, which represented
the normalized reflectivity change. All experiments were
carried out at room temperature, and a flow rate of 30 μL/
min was used.
Statistical analysis
The mean value and standard deviation [SD] were cal-
culated using the Sigmaplot 10.0 (Systat Software, Inc.,
Table 1 MTB antigens used in the study which were
previously purified in the laboratory
Antigen number Category
W06 Secreted protein
W10 Secreted protein
W14 Heat shock protein
W19 Lipoprotein
W28 Secreted protein
W38 Lipoprotein
W64 Secreted protein
W70 Secreted protein
W85 Fibronectin-binding protein
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from the mean value plus twofold SD from the healthy
group. This threshold value was used to classify indivi-
duals as positive or negative of the TB infection. Detec-
tion sensitivity, specificity, positive predictive value
[PPV], and negative predictive value [NPV] were calcu-
lated by standard statistical methods [24].
Results and discussion
SPR-based immunoassays for TB detection
Multiplex detection of TB antibody was accomplished by
combining nine immunoassays onto one sensor chip.
Serum specimens from TB patients were distinguishable
from control specimens of healthy individuals. Figure 2
showed the real-time SPR binding curves in the injection
of sample, while the PBS buffer was used for the SPR run-
ning buffer. These results were obtained using the V++
software to acquire relative quantitative reflectivities for
the array spots. To properly normalize the reflectance
values, the maximum signal was assigned a mean value of
1. Normalizing on the maximum SPR responses was to
compare different array chips. Injection of a serum sample
of a TB patient, but not a healthy donor, caused an initial
increase and then the stabilization of the signal
response corresponding to the spot bearing the TB antigen
(Figure 2). This sample induced a significant response in
reflectivity (R > 0.6) from the W14 spot, revealing the pre-
s e n c eo fas p e c i f i ca n t i b o d ya g a i n s tt h i sa n t i g e ni nt h e
patient-derived serum. Lower reflectivities (0.2 to 0.5)
from all spots were observed in the use of healthy donors
under the same condition. Additionally, the reflectivities of
the negative control experiments were typically lower than
0.02. Thus, the detection signal, reflectivity, is at least two
orders-of-magnitude higher than in the negative control.
The SPR reflectivity from the healthy individual did
increase slightly, illustrating that there might be a small
amount of the target antibody for the antigen spots rela-
tive to the negative control. However, these levels of anti-
bodies against each antigen in TB patients were higher
than those in healthy controls.
Antibodies from patient samples on our SPR array were
validated for functionality by interaction with the antigen
immobilized on the sensor array. In most cases, signals
from normal control were very low, and positive array sig-
nals from the patient sample were strong and easily identi-
fiable. However, in our study, the SPR response had a
slight increase from the healthy individual (Figure 3).
Thus, when discriminating between TB and non-TB
patients, it was necessary to set a threshold for detection
of the serum sample. Although a higher threshold value
would mean fewer false positive results, false negative
values would increase. By contrast, lower cutoff threshold
had the opposite effect. To determine a cutoff value for a
positive result, the SPR reflectivities of the six normal indi-
viduals were averaged for this SPR sensor reference. Here,
95% confidence intervals for the SPR test were chosen as
the cutoff threshold. Therefore, a threshold value of 0.58
(mean + twofold SD) was used to identify TB infection.
Diagnostic assessment of the SPR array
The sensitivity, specificity, PPV, and NPV of the SPR-
based antigen array were compared with those of the
commercial ELISA tests. Serum from 29 TB patients
and 28 healthy individuals were evaluated by the use of
this cutoff value. As shown in Table 2, the specificity of
the SPR-based sensor was all above 90% (93% to 100%),
whereas the sensitivity ranged from 14% to 79%. On the
other hand, ELISA exhibited similar results with the
specificity (79% to 100%) but had a weaker sensitivity
(10% to 62%). These results demonstrated that the use
of the SPR sensor had the potential to discriminate
between TB and non-TB patients.
Figure 1 On-chip TB screening using SPR. SPR image of the microarrayed chip (left) and the configuration of the SPR array chip (right).
Numbers shown in the experiment set indicate the molecular weight of each purified MTB antigen. Positive control means the mixture of MTB
antigens used for antibody challenge from rabbits. The BSA was used as the negative control.
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superior to the use of a single, antigen-based assay
[25,26]. Thus, the sensitivity and specificity of the multi-
ple-antigen ELISA system was compared to those of the
SPR array system. As shown in Table 2, the multiple-
antigen test provided more accuracy in detecting TB,
increasing sensitivity of diagnosis, and facilitating interro-
gation of sample components simultaneously. The results
in the array-based SPR sensor were similar to those
obtained for the multiple-antigen ELISA assay. When
comparing the sensitivity and specificity in the diagnosis
of TB patients, the multiple-antigen strategies for SPR
and ELISA systems performed better than the single-
antigen tests for those assays. However, the performance
of this multiplexed measurement for SPR sensor was still
higher than that of multiple-antigen ELISA in terms of
sensitivity (100%, 90%), specificity (89%, 57%), PPV (91%,
68%), and NPV (100%, 84%). Hence, this SPR-based anti-
gen array has great potential in the rapid identification of
TB infection.
Conclusion
Simultaneous determination of nine TB antibodies in
serum had been accomplished with an array-based SPR
system. In comparison with ELISA using enzyme or sec-
ondary antibody as a single label, SPR was more advanta-
geous in providing label-free and real-time detection.
Additionally, this SPR-based antigen array had high speci-
ficity and sensitivity for the detection of TB infection. This
assay showed excellent promise for further development
Figure 2 SPR sensograms correspond to the injection of 10-fold diluted sera into an array-format SPR sensor.( a) SPR results from TB
patient sera and (b) SPR results from normal control sera. All experiments were carried out at room temperature in triplicate, and a flow rate of
30 μL/min was used. Results shown were averages of three independent experiments.
Figure 3 Comparison of the results. Comparison of the results obtained from serum samples of normal individuals and patients determined
by SPR array-based screening assay. Results were averages of three independent experiments (p < 0.05).
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Acknowledgements
This work was supported by grants from the National Science Council (NSC-
100-2325-B-182-005), the Department of Health (DOH100-TD-N-111-001), and
the Chang Gung Memorial Hospital (CMRPD190302) which were really
appreciated.
Author details
1Graduate Institute of Medical Biotechnology and Laboratory Science, and
Research Center for Pathogenic Bacteria, Chang Gung University, No. 259,
Wen-Hwa 1st Road, Kwei-Shan, Tao-Yuan, 333, Taiwan
2Institute of
Biomedical Engineering, National Taiwan University, No. 1, Sec. 4, Roosevelt
Road, Taipei, 10617, Taiwan
3Department of Respiratory Therapy, College of
Medicine, Fu Jen Catholic University, No. 510, Zhongzheng Road, Xinzhung
District, New Taipei City, 24205, Taiwan
4Center for Emerging Material and
Advanced Devices, National Taiwan University, No. 1, Sec. 4, Roosevelt Road,
Taipei, 10617, Taiwan
Authors’ contributions
S-CH and C-CC participated in the research design. S-CH, C-CC, C-FW, and C-
SL conducted the experiments. H-CL and C-WL contributed the analytic
tools. S-CH, C-CC, and C-CL analyzed the data. H-CL and C-WL wrote the
paper. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 30 November 2011 Accepted: 8 March 2012
Published: 8 March 2012
References
1. Soo PC, Horng YT, Chang KC, Wang JY, Hsueh PR, Chuang CY, Lu CC,
Lai HC: A simple gold nanoparticle probes assay for identification of
Mycobacterium tuberculosis and Mycobacterium tuberculosis complex
from clinical specimens. Mol Cell Probes 2009, 23:240-246.
2. Dye C, Lonnroth K, Jaramillo E, Williams BG, Raviglione M: Trends in
tuberculosis incidence and their determinants in 134 countries. Bull
World Health Organ 2009, 87:683-691.
3. Soo PC, Horng YT, Hsueh PR, Shen BJ, Wang JY, Tu HH, Wei JR, Hsieh SC,
Huang CC, Lai HC: Direct and simultaneous identification of
Mycobacterium tuberculosis complex (MTBC) and Mycobacterium
tuberculosis (MTB) by rapid multiplex nested PCR-ICT assay. J Microbiol
Methods 2006, 66:440-448.
4. Young DB, Perkins MD, Duncan K, Barry CE III: Confronting the scientific
obstacles to global control of tuberculosis. JC l i nI n v e s t2008, 118:1255-1265.
5. Brisson-Noel A, Aznar C, Chureau C, Nguyen S, Pierre C, Bartoli M, Bonete R,
Pialoux G, Gicquel B, Garrigue G: Diagnosis of tuberculosis by DNA
amplification in clinical practice evaluation. Lancet 1991, 338:364-366.
6. Li H, Turhan V, Chokhani L, Stratton CW, Dunbar SA, Tang YW:
Identification and differentiation of clinically relevant mycobacterium
species directly from acid-fast bacillus-positive culture broth. J Clin
Microbiol 2009, 47:3814-3820.
7. Mdivani N, Li H, Akhalaia M, Gegia M, Goginashvili L, Kernodle DS,
Khechinashvili G, Tang YW: Monitoring therapeutic efficacy by real-time
detection of Mycobacterium tuberculosis mRNA in sputum. Clin Chem
2009, 55:1694-1700.
8. Chan ED, Heifets L, Iseman MD: Immunologic diagnosis of tuberculosis: a
review. Tuber Lung Dis 2000, 80:131-140.
9. Steingart KR, Henry M, Ng V, Hopewell PC, Ramsay A, Cunningham J,
Urbanczik R, Perkins M, Aziz MA, Pai M: Fluorescence versus conventional
sputum smear microscopy for tuberculosis: a systematic review. Lancet
Infect Dis 2006, 6:570-581.
10. Drobniewski FA, Caws M, Gibson A, Young D: Modern laboratory
diagnosis of tuberculosis. Lancet Infect Dis 2003, 3:141-147.
11. Prasek J, Huska D, Jasek O, Zajickova L, Trnkova L, Adam V, Kizek R,
Hubalek J: Carbon composite micro- and nano-tubes-based electrodes
for detection of nucleic acids. Nanoscale Res Lett 2011, 6:385.
12. Silva LB, Veigas B, Doria G, Costa P, Inácio J, Martins R, Fortunato E,
Baptista PV: Portable optoelectronic biosensing platform for identification
of mycobacteria from the Mycobacterium tuberculosis complex. Biosens
Bioelectron 2011, 26:2012-2017.
13. Yeo WH, Liu S, Chung JH, Liu Y, Lee KH: Rapid detection of
Mycobacterium tuberculosis cells by using microtip-based immunoassay.
Anal Bioanal Chem 2009, 393:1593-1600.
14. Gennaro ML: Immunologic diagnosis of tuberculosis. Clin Infect Dis 2000,
30:S243-S246.
15. Steingart KR, Henry M, Laal S, Hopewell PC, Ramsay A, Menzies D,
Cunningham J, Weldingh K, Pai M: Commercial serological antibody
detection tests for the diagnosis of pulmonary tuberculosis: a systematic
review. PLoS Med 2007, 4:e202.
16. Gauglitz G: Direct optical detection in bioanalysis: an update. Anal
Bioanal Chem 2010, 398:2363-2372.
17. Chang CC, Chiu NF, Lin DS, Chu-Su Y, Liang YH, Lin CW: High-sensitivity
detection of carbohydrate antigen 15-3 using a gold/zinc oxide thin film
surface plasmon resonance-based biosensor. Anal Chem 2010,
82:1207-1212.
18. Lepage D, Carrier D, Jiménez A, Beauvais J, Dubowski JJ: Plasmonic
propagations distances for interferometric surface plasmon resonance
biosensing. Nanoscale Res Lett 2011, 6:388.
19. Hong S, Lee S, Yi J: Sensitive and molecular size-selective detection of
proteins using a chip-based and heteroliganded gold nanoisland by
localized surface plasmon resonance spectroscopy. Nanoscale Res Lett
2011, 6:336.
Table 2 Results of sensitivity, specificity, PPV, and NPV of SPR array compared to ELISA assay results
Antigen number
a Sensitivity (%)
b Specificity (%)
b PPV (%)
b NPV (%)
b
SPR ELISA SPR ELISA SPR ELISA SPR ELISA
W06 79 10 96 100 96 100 82 52
W10 45 38 100 96 100 92 64 60
W14 59 24 100 96 100 88 70 55
W19 31 62 96 79 90 75 57 67
W28 86 34 93 96 93 91 87 59
W38 79 24 100 100 100 100 82 56
W64 69 17 100 93 100 71 76 53
W70 14 24 100 100 100 100 53 56
W85 76 28 96 96 96 89 79 56
Multi-Ag 100 90 89 57 91 68 100 84
aA total of nine M. tuberculosis related antigens were used for the test.
bResults shown were averages of three independent experiments. PPV, positive predictive
value; NPV, negative predictive value; SPR, surface plasmon resonance; ELISA, enzyme-linked immunosorbent assay; Ag, antigen.
Hsieh et al. Nanoscale Research Letters 2012, 7:180
http://www.nanoscalereslett.com/content/7/1/180
Page 5 of 620. Chang CC, Lin S, Wei SC, Chen CY, Lin CW: An amplified surface plasmon
resonance “turn-on” sensor for mercury ion using gold nanoparticles.
Biosens Bioelectron 2011, 30:235-240.
21. Dorokhin D, Haasnoot W, Franssen MCR, Zuilhof H, Nielen MWF: Imaging
surface plasmon resonance for multiplex microassay sensing of
mycotoxins. Anal Bioanal Chem 2011, 400:3005-3011.
22. Otsuki S, Ishikawa M: Wavelength-scanning surface plasmon resonance
imaging for label-free multiplexed protein microarray assay. Biosens
Bioelectron 2010, 26:202-206.
23. Chen Y, Nguyen A, Niu L, Corn RM: Fabrication of DNA microarrays with
poly(L-glutamic acid) monolayers on gold substrates for SPR imaging
measurements. Langmuir 2009, 25:5054-5060.
24. Feinstein AR: Clinical biostatistics. XXXIII. On teaching statistics to
medical students. Clin Pharmacol Ther 1975, 18:121-126.
25. Houghton RL, Lodes MJ, Dillon DC, Reynolds LD, Day CH, McNeill PD,
Hendrickson RC, Skeiky YA, Sampaio DP, Badaro R, Lyashchenko KP,
Reed SG: Use of multiepitope polyproteins in serodiagnosis of active
tuberculosis. Clin Diagn Lab Immunol 2002, 9:883-891.
26. Moran AJ, Treit JD, Whitney JL, Abomoelak B, Houghton R, Skeiky YA,
Sampaio DP, Badaro R, Nano FE: Assessment of the serodiagnostic
potential of nine novel proteins from Mycobacterium tuberculosis. FEMS
Microbiol Lett 2001, 198:31-36.
doi:10.1186/1556-276X-7-180
Cite this article as: Hsieh et al.: Rapid identification of Mycobacterium
tuberculosis infection by a new array format-based surface plasmon
resonance method. Nanoscale Research Letters 2012 7:180.
Submit your manuscript to a 
journal and beneﬁ  t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ  eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
Hsieh et al. Nanoscale Research Letters 2012, 7:180
http://www.nanoscalereslett.com/content/7/1/180
Page 6 of 6